NASDAQ:GH - Guardant Health Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$36.70 +0.46 (+1.27 %)
(As of 12/18/2018 12:37 PM ET)
Previous Close$36.24
Today's Range$35.95 - $37.43
52-Week Range$27.04 - $49.55
Volume5,214 shs
Average Volume629,786 shs
Market Capitalization$3.41 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Guardant Health, Inc., a precision oncology company, provides non-invasive cancer diagnostics. It offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes from circulating tumor DNA (ctDNA); and GuardantOMNI, a broader panel measuring various genes from ctDNA. The company also provides LUNAR-1 for recurrence detection in cancer survivors; and LUNAR-2 for early detection of cancer in higher risk individuals. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California.

Receive GH News and Ratings via Email

Sign-up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Medical laboratories
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:GH
Previous Symbol
CUSIPN/A
Phone855-698-8887

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees348
Outstanding Shares85,750,000
Market Cap$3.41 billion
OptionableNot Optionable

Guardant Health (NASDAQ:GH) Frequently Asked Questions

What is Guardant Health's stock symbol?

Guardant Health trades on the NASDAQ under the ticker symbol "GH."

How were Guardant Health's earnings last quarter?

Guardant Health Inc (NASDAQ:GH) posted its earnings results on Monday, November, 19th. The company reported ($1.94) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.29) by $1.65. The firm earned $21.70 million during the quarter, compared to the consensus estimate of $17.44 million. The business's revenue for the quarter was up 95.5% on a year-over-year basis. View Guardant Health's Earnings History.

When is Guardant Health's next earnings date?

Guardant Health is scheduled to release their next quarterly earnings announcement on Monday, February 18th 2019. View Earnings Estimates for Guardant Health.

What guidance has Guardant Health issued on next quarter's earnings?

Guardant Health updated its FY 2018 earnings guidance on Monday, November, 19th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $82-84 million, compared to the consensus revenue estimate of $74.47 million.

What price target have analysts set for GH?

5 Wall Street analysts have issued twelve-month price objectives for Guardant Health's shares. Their predictions range from $37.00 to $42.00. On average, they expect Guardant Health's stock price to reach $39.50 in the next year. This suggests a possible upside of 7.6% from the stock's current price. View Analyst Price Targets for Guardant Health.

What is the consensus analysts' recommendation for Guardant Health?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Guardant Health in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Guardant Health.

Has Guardant Health been receiving favorable news coverage?

Media coverage about GH stock has been trending somewhat positive on Tuesday, according to InfoTrie. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Guardant Health earned a daily sentiment score of 2.0 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 8.0 out of 10, indicating that recent news coverage is very likely to have an effect on the stock's share price in the near term.

Are investors shorting Guardant Health?

Guardant Health saw a increase in short interest in the month of November. As of November 15th, there was short interest totalling 1,064,134 shares, an increase of 46.2% from the October 31st total of 727,769 shares. Based on an average daily trading volume, of 360,287 shares, the days-to-cover ratio is presently 3.0 days. Approximately 3.8% of the company's shares are short sold. View Guardant Health's Current Options Chain.

Who are some of Guardant Health's key competitors?

Who are Guardant Health's key executives?

Guardant Health's management team includes the folowing people:
  • Mr. AmirAli Talasaz, Chairman, Pres & COO (Age 39)
  • Dr. Helmy Eltoukhy Ph.D., Co-Founder, CEO & Director (Age 39)
  • Mr. Michael J. Wiley, Chief Legal Officer (Age 43)
  • Mr. Derek A. Bertocci, Chief Financial Officer (Age 64)
  • Dr. Richard B. Lanman, Chief Medical Officer (Age 63)

When did Guardant Health IPO?

(GH) raised $200 million in an initial public offering (IPO) on Thursday, October 4th 2018. The company issued 12,500,000 shares at $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch acted as the underwriters for the IPO and Cowen, Leerink Partners and William Blair were co-managers.

When does the company's lock-up period expire?

Guardant Health's lock-up period expires on Tuesday, April 2nd. Guardant Health had issued 12,500,000 shares in its IPO on October 4th. The total size of the offering was $237,500,000 based on an initial share price of $19.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the expiration of the lock-up period.

How do I buy shares of Guardant Health?

Shares of GH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Guardant Health's stock price today?

One share of GH stock can currently be purchased for approximately $36.70.

How big of a company is Guardant Health?

Guardant Health has a market capitalization of $3.41 billion. Guardant Health employs 348 workers across the globe.

What is Guardant Health's official website?

The official website for Guardant Health is http://www.guardanthealth.com.

How can I contact Guardant Health?

Guardant Health's mailing address is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063. The company can be reached via phone at 855-698-8887.


MarketBeat Community Rating for Guardant Health (NASDAQ GH)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  31 (Vote Outperform)
Underperform Votes:  35 (Vote Underperform)
Total Votes:  66
MarketBeat's community ratings are surveys of what our community members think about Guardant Health and other stocks. Vote "Outperform" if you believe GH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel